CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol?chitosan (CBD?CHT) formulation for dyslipidemia, today announced the successful completion of its ...
Along with Republican supermajorities in the Louisiana Legislature, Gov. Jeff Landry and his cabinet have pursued an ...
Progress report: The Blue Jays have not rested on the laurels from their 2025 pennant. Even after adding Kazuma Okamoto, ...
Jade Biosciences, Inc. ( JBIO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 2:15 PM EST ...
And then biotech does what biotech always does. It reminds you that in this corner of the market, the business is not the ...
Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...
Zacks Investment Research on MSN
Is Novo Nordisk's oral Wegovy driving strong early US demand already?
Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just ...
Zacks Investment Research on MSN
Will NVO's Wegovy pill approval for obesity be a game changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce ...
ANI Pharmaceuticals’ ANIP stock has risen 21% in the past six months, all thanks to the encouraging financial performance of ...
Shiba Inu volume spikes 74% to $175M as burn rate jumps 249%. Analysts say the asset is coiling for a breakout above the ...
Dr Mike McDonagh provides insight into the factors involved in choosing and processing suitable alternative antimony alloys for lead-acid battery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results